1	Subject has been maintained on a stable dose regimen of 1 to 2 non-benzodiazepine marketed Anti-epileptic drugs AEDs OR 1 to 3 AEDs with at least 1 AED identified as a benzodiazepine for at least 28 days prior to Visit 1 with or without additional concurrent stable Vagus nerve stimulation VNS|benzodiazepine[67,81]|||||||28 days[196,203]|||1402|1402|benzodiazepine
1	Subject has been maintained on a stable dose regimen of 1 to 2 non-benzodiazepine marketed Anti-epileptic drugs AEDs OR 1 to 3 AEDs with at least 1 AED identified as a benzodiazepine for at least 28 days prior to Visit 1 with or without additional concurrent stable Vagus nerve stimulation VNS|benzodiazepine[168,182]||||||||||1402|1402|benzodiazepine
